National Toxicology Program (NTP); Office of Liaison, Policy and Review; Meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM), 19562-19563 [E9-9845]
Download as PDF
19562
Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices
Æ 1 member shall be from a labor
organization representing health care
workers;
Æ 1 member shall have expertise in
health information privacy and security;
Æ 1 member shall have expertise in
improving the health of vulnerable
populations;
Æ 1 member shall be from the
research community;
Æ 1 member shall represent health
plans or other third-party payers;
Æ 1 member shall represent
information technology vendors;
Æ 1 member shall represent
purchasers or employers; and
Æ 1 member shall have expertise in
health care quality measurement and
reporting.
Non-federal members of the
Committee shall be Special Government
Employees, unless classified as
representatives.
III. Copies of the Charter
Dated: April 23, 2009.
David Blumenthal,
National Coordinator for Health Information
Technology, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. E9–9839 Filed 4–24–09; 4:15 pm]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology
pwalker on PROD1PC71 with NOTICES
ACTION: Notification of the
Establishment of the HIT Standards
Committee.
SUMMARY: This notice announces the
establishment of the HIT Standards
Committee. The American Recovery and
Reinvestment Act of 2009 (ARRA) (Pub.
L. 111–5), section 13101, directs the
establishment of the HIT Standards
Committee. The HIT Standards
Committee (also referred to as the
‘‘Committee’’) is charged with making
recommendations to the National
Coordinator on standards,
implementation specifications, and
certification criteria for the electronic
exchange and use of health information
for purposes of adoption, consistent
with the implementation of the Federal
Health IT Strategic Plan, and in
accordance with policies developed by
the HIT Policy Committee.
FOR FURTHER INFORMATION CONTACT:
Judith Sparrow, Office of the National
17:48 Apr 28, 2009
SUPPLEMENTARY INFORMATION:
I. Background
The Committee and its staff are
governed by the provisions of the
Federal Advisory Committee Act
(FACA) (Pub. L. 92–463), as amended,
(5 U.S.C. App.), which sets forth
standards for the formation and use of
federal advisory committees.
The Committee shall determine a
schedule of meetings following an
election of a Chairperson and a Vice
Chairperson from among its members.
An initial meeting of the Committee
shall take place not later than 90 days
from passage of the ARRA.
II. Criteria for Members
To obtain a copy of the Committee’s
charter, submit a written request to the
above contact.
VerDate Nov<24>2008
Coordinator for Health Information
Technology, e-mail
judy.sparrow@hhs.gov or 202–205–
4528.
Jkt 217001
The HIT Standards Committee shall
not exceed thirty (30) voting members,
including a Chair and Vice Chair, and
members are appointed by the Secretary
with input from the National
Coordinator. Membership of the
Committee shall at least reflect
providers, ancillary healthcare workers,
consumers, purchasers, health plans,
technology vendors, researchers,
relevant Federal agencies, and
individuals with technical expertise on
health care quality, privacy and
security, and on the electronic exchange
and use of health information and shall
represent a balance among various
sectors of the health care system so that
no single sector unduly influences the
recommendations of the Committee.
Non-Federal members of the
Committee shall be Special Government
Employees, unless classified as
representatives.
III. Copies of the Charter
To obtain a copy of the Committee’s
charter, submit a written request to the
above contact.
Dated: April 23, 2009.
David Blumenthal,
National Coordinator for Health Information
Technology, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. E9–9838 Filed 4–24–09; 4:15 pm]
BILLING CODE 4150–45–P
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP);
Office of Liaison, Policy and Review;
Meeting of the Scientific Advisory
Committee on Alternative
Toxicological Methods (SACATM)
AGENCY: National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health
(NIH).
ACTION: Meeting announcement and
request for comments.
SUMMARY: Pursuant to section 10(a) of
the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of
SACATM on June 25–26, 2009, at the
Hilton Arlington Hotel, 950 North
Stafford Street, Arlington, VA 22203.
The meeting is open to the public with
attendance limited only by the space
available. SACATM advises the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM), the NTP Interagency Center
for the Evaluation of Alternative
Toxicological Methods (NICEATM), and
the Director of the NIEHS and NTP
regarding statutorily mandated duties of
ICCVAM and activities of NICEATM.
DATES: The SACATM meeting will be
held on June 25 and 26, 2009. The
meeting is scheduled from 8:30 a.m. to
5 p.m. on June 25 and 8:30 a.m. until
adjournment on June 26, 2009. All
individuals who plan to attend are
encouraged to register online at the NTP
Web site (https://ntp.niehs.nih.gov/go/
7441) by June 17, 2009. In order to
facilitate planning, persons wishing to
make an oral presentation are asked to
notify Dr. Lori White, NTP Executive
Secretary, via online registration, phone,
or e-mail by June 17, 2009 (see
ADDRESSES below). Written comments
should also be received by June 17,
2009, to enable review by SACATM and
NIEHS/NTP staff before the meeting.
ADDRESSES: The SACATM meeting will
be held at the Hilton Arlington Hotel,
950 North Stafford Street, Arlington, VA
22203 [hotel: (703) 528–6000)]. Public
comments and other correspondence
should be directed to Dr. Lori White
(NTP Office of Liaison, Policy and
Review, NIEHS, P.O. Box 12233, MD
K2–03, Research Triangle Park, NC
27709; telephone: 919–541–9834 or email: whiteld@niehs.nih.gov). Courier
address: NIEHS, 530 Davis Drive, Room
2136, Durham, NC 27713. Persons
needing interpreting services in order to
attend should contact 301–402–8180
(voice) or 301–435–1908 (TTY).
E:\FR\FM\29APN1.SGM
29APN1
Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices
allowed for presentation by on-site
registrants may be less than for preregistered speakers and will be
determined by the number of persons
Preliminary Agenda Topics and
who register at the meeting.
Availability of Meeting Materials
Persons registering to make oral
comments are asked to do so through
Preliminary agenda topics include:
the online registration form (https://
• NICEATM–ICCVAM Update.
• Regulatory Acceptance of ICCVAM– ntp.niehs.nih.gov/go/7441) and to send
a copy of their statement to Dr. White
Recommended Alternative Test
(see ADDRESSES above) by June 17, 2009,
Methods.
• NRC Report Recognition and
to enable review by SACATM,
Alleviation of Pain in Laboratory
NICEATM–ICCVAM, and NIEHS/NTP
Animals.
staff prior to the meeting. Written
• Implementation of NICEATM–
statements can supplement and may
ICCVAM Five-Year Plan.
expand the oral presentation. If
• Federal Agency Research,
registering on-site and reading from
Development, Translation, and
written text, please bring 40 copies of
Validation Activities Relevant to the
the statement for distribution and to
NICEATM–ICCVAM Five-Year Plan
supplement the record.
(EPA and USDA).
Background Information on ICCVAM,
• Report on second meeting of
NICEATM, and SACATM
Independent Peer Review Panel:
ICCVAM is an interagency committee
Evaluation of the Updated Validation
composed of representatives from 15
Status of New Versions and
Federal regulatory and research agencies
Applications of the Murine Local
that use, generate, or disseminate
Lymph Node Assay: Assessing the
toxicological information. ICCVAM
Allergic Contact Dermatitis Potential of
conducts technical evaluations of new,
Chemicals and Products.
revised, and alternative methods with
• Report on the Independent
regulatory applicability and promotes
Scientific Peer Review Panel on
the development, scientific validation,
Alternative Ocular Safety Testing
regulatory acceptance, implementation,
Methods.
• Update from the Japanese Center for and national and international
harmonization of new, revised, and
the Validation of Alternative Methods.
alternative toxicological test methods
• Update from the European Centre
that more accurately assess the safety
for the Evaluation of Alternative
and hazards of chemicals and products
Methods.
and that refine, reduce, and replace
• Update from Health Canada.
A copy of the preliminary agenda,
animal use. The ICCVAM Authorization
committee roster, and additional
Act of 2000 [42 U.S.C. 285l–3]
information, when available, will be
established ICCVAM as a permanent
interagency committee of the NIEHS
posted on the NTP Web site (https://
under NICEATM. NICEATM
ntp.niehs.nih.gov/go/7441) or available
administers ICCVAM and provides
upon request (see ADDRESSES above).
scientific and operational support for
Following the SACATM meeting,
ICCVAM-related activities. NICEATM
summary minutes will be prepared and
and ICCVAM work collaboratively to
available on the NTP Web site or upon
evaluate new and improved test
request.
methods applicable to the needs of U.S.
Request for Comments
Federal agencies. Additional
Both written and oral public input on information about ICCVAM and
the agenda topics is invited. Written
NICEATM can be found on their Web
comments received in response to this
site (https://iccvam.niehs.nih.gov).
notice will be posted on the NTP Web
SACATM was established in response
site. Persons submitting written
to the ICCVAM Authorization Act
comments should include their name,
[Section 285l–3(d)] and is composed of
affiliation (if applicable), and
scientists from the public and private
sponsoring organization (if any) with
sectors. SACATM advises ICCVAM,
the document. Time is allotted during
NICEATM, and the Director of the
the meeting for presentation of oral
NIEHS and NTP regarding statutorily
comments and each organization is
mandated duties of ICCVAM and
allowed one time slot per public
activities of NICEATM. SACATM
comment period. At least 7 minutes will provides advice on priorities and
be allotted for each speaker, and if time
activities related to the development,
permits, may be extended up to 10
validation, scientific review, regulatory
minutes at the discretion of the chair.
acceptance, implementation, and
Registration for oral comments will also national and international
be available on-site, although time
harmonization of new, revised, and
pwalker on PROD1PC71 with NOTICES
Requests should be made at least 7 days
in advance of the meeting.
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
17:48 Apr 28, 2009
Jkt 217001
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
19563
alternative toxicological test methods.
Additional information about SACATM,
including the charter, roster, and
records of past meetings, can be found
at https://ntp.niehs.nih.gov/go/167.
Dated: April 22, 2009.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. E9–9845 Filed 4–28–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-09–0128]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Congenital Syphilis (CS) Case
Investigation and Report Form
(CDC73.126), OMB No. 0920–0128—
revision—National Center for HIV/
AIDS, Viral Hepatitis, Sexually
Transmitted Diseases, and Tuberculosis
Prevention, (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
E:\FR\FM\29APN1.SGM
29APN1
Agencies
[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Pages 19562-19563]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9845]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Toxicology Program (NTP); Office of Liaison, Policy and
Review; Meeting of the Scientific Advisory Committee on Alternative
Toxicological Methods (SACATM)
AGENCY: National Institute of Environmental Health Sciences (NIEHS),
National Institutes of Health (NIH).
ACTION: Meeting announcement and request for comments.
-----------------------------------------------------------------------
SUMMARY: Pursuant to section 10(a) of the Federal Advisory Committee
Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a
meeting of SACATM on June 25-26, 2009, at the Hilton Arlington Hotel,
950 North Stafford Street, Arlington, VA 22203. The meeting is open to
the public with attendance limited only by the space available. SACATM
advises the Interagency Coordinating Committee on the Validation of
Alternative Methods (ICCVAM), the NTP Interagency Center for the
Evaluation of Alternative Toxicological Methods (NICEATM), and the
Director of the NIEHS and NTP regarding statutorily mandated duties of
ICCVAM and activities of NICEATM.
DATES: The SACATM meeting will be held on June 25 and 26, 2009. The
meeting is scheduled from 8:30 a.m. to 5 p.m. on June 25 and 8:30 a.m.
until adjournment on June 26, 2009. All individuals who plan to attend
are encouraged to register online at the NTP Web site (https://ntp.niehs.nih.gov/go/7441) by June 17, 2009. In order to facilitate
planning, persons wishing to make an oral presentation are asked to
notify Dr. Lori White, NTP Executive Secretary, via online
registration, phone, or e-mail by June 17, 2009 (see ADDRESSES below).
Written comments should also be received by June 17, 2009, to enable
review by SACATM and NIEHS/NTP staff before the meeting.
ADDRESSES: The SACATM meeting will be held at the Hilton Arlington
Hotel, 950 North Stafford Street, Arlington, VA 22203 [hotel: (703)
528-6000)]. Public comments and other correspondence should be directed
to Dr. Lori White (NTP Office of Liaison, Policy and Review, NIEHS,
P.O. Box 12233, MD K2-03, Research Triangle Park, NC 27709; telephone:
919-541-9834 or e-mail: whiteld@niehs.nih.gov). Courier address: NIEHS,
530 Davis Drive, Room 2136, Durham, NC 27713. Persons needing
interpreting services in order to attend should contact 301-402-8180
(voice) or 301-435-1908 (TTY).
[[Page 19563]]
Requests should be made at least 7 days in advance of the meeting.
SUPPLEMENTARY INFORMATION:
Preliminary Agenda Topics and Availability of Meeting Materials
Preliminary agenda topics include:
NICEATM-ICCVAM Update.
Regulatory Acceptance of ICCVAM-Recommended Alternative
Test Methods.
NRC Report Recognition and Alleviation of Pain in
Laboratory Animals.
Implementation of NICEATM-ICCVAM Five-Year Plan.
Federal Agency Research, Development, Translation, and
Validation Activities Relevant to the NICEATM-ICCVAM Five-Year Plan
(EPA and USDA).
Report on second meeting of Independent Peer Review Panel:
Evaluation of the Updated Validation Status of New Versions and
Applications of the Murine Local Lymph Node Assay: Assessing the
Allergic Contact Dermatitis Potential of Chemicals and Products.
Report on the Independent Scientific Peer Review Panel on
Alternative Ocular Safety Testing Methods.
Update from the Japanese Center for the Validation of
Alternative Methods.
Update from the European Centre for the Evaluation of
Alternative Methods.
Update from Health Canada.
A copy of the preliminary agenda, committee roster, and additional
information, when available, will be posted on the NTP Web site (https://ntp.niehs.nih.gov/go/7441) or available upon request (see ADDRESSES
above). Following the SACATM meeting, summary minutes will be prepared
and available on the NTP Web site or upon request.
Request for Comments
Both written and oral public input on the agenda topics is invited.
Written comments received in response to this notice will be posted on
the NTP Web site. Persons submitting written comments should include
their name, affiliation (if applicable), and sponsoring organization
(if any) with the document. Time is allotted during the meeting for
presentation of oral comments and each organization is allowed one time
slot per public comment period. At least 7 minutes will be allotted for
each speaker, and if time permits, may be extended up to 10 minutes at
the discretion of the chair. Registration for oral comments will also
be available on-site, although time allowed for presentation by on-site
registrants may be less than for pre-registered speakers and will be
determined by the number of persons who register at the meeting.
Persons registering to make oral comments are asked to do so
through the online registration form (https://ntp.niehs.nih.gov/go/7441)
and to send a copy of their statement to Dr. White (see ADDRESSES
above) by June 17, 2009, to enable review by SACATM, NICEATM-ICCVAM,
and NIEHS/NTP staff prior to the meeting. Written statements can
supplement and may expand the oral presentation. If registering on-site
and reading from written text, please bring 40 copies of the statement
for distribution and to supplement the record.
Background Information on ICCVAM, NICEATM, and SACATM
ICCVAM is an interagency committee composed of representatives from
15 Federal regulatory and research agencies that use, generate, or
disseminate toxicological information. ICCVAM conducts technical
evaluations of new, revised, and alternative methods with regulatory
applicability and promotes the development, scientific validation,
regulatory acceptance, implementation, and national and international
harmonization of new, revised, and alternative toxicological test
methods that more accurately assess the safety and hazards of chemicals
and products and that refine, reduce, and replace animal use. The
ICCVAM Authorization Act of 2000 [42 U.S.C. 285l-3] established ICCVAM
as a permanent interagency committee of the NIEHS under NICEATM.
NICEATM administers ICCVAM and provides scientific and operational
support for ICCVAM-related activities. NICEATM and ICCVAM work
collaboratively to evaluate new and improved test methods applicable to
the needs of U.S. Federal agencies. Additional information about ICCVAM
and NICEATM can be found on their Web site (https://iccvam.niehs.nih.gov).
SACATM was established in response to the ICCVAM Authorization Act
[Section 285l-3(d)] and is composed of scientists from the public and
private sectors. SACATM advises ICCVAM, NICEATM, and the Director of
the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and
activities of NICEATM. SACATM provides advice on priorities and
activities related to the development, validation, scientific review,
regulatory acceptance, implementation, and national and international
harmonization of new, revised, and alternative toxicological test
methods. Additional information about SACATM, including the charter,
roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/167.
Dated: April 22, 2009.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. E9-9845 Filed 4-28-09; 8:45 am]
BILLING CODE 4140-01-P